Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

Summary

Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis is a clinical trial^[1].

Key Facts

• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis is in the country of Argentina^[2].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis is in the country of Australia^[3].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis is in the country of Belgium^[4].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis is in the country of Chile^[5].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis is in the country of Germany^[6].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis is in the country of Netherlands^[7].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's instance of is recorded as clinical trial^[8].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's start time is recorded as +2009-11-30T00:00:00Z^[9].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's end time is recorded as +2014-01-31T00:00:00Z^[10].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's sponsor is recorded as Pharmaxis (United Kingdom)^[11].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's main subject is recorded as bronchiectasis^[12].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's number of participants is recorded as {'unit': '1', 'amount': '+485'}^[13].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's title is recorded as : A Phase III Multicenter, Randomized, Parallel Group, Controlled, Double Blind Study to Investigate the Safety and Efficacy of Inhaled Mannitol Over 12 Months in the Treatment of Bronchiectasis.^[14].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[15].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's ClinicalTrials.gov ID is recorded as NCT00669331^[16].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+85'}^[17].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research intervention is recorded as D-(-)-mannitol^[18].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's clinical trial phase is recorded as phase III clinical trial^[19].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research site is recorded as Georgetown University^[20].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research site is recorded as University of Miami^[21].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research site is recorded as University of Chicago^[22].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research site is recorded as Temple University Hospital^[23].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research site is recorded as St George Hospital^[24].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research site is recorded as The Prince Charles Hospital^[25].
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis's research site is recorded as Royal Adelaide Hospital^[26].